Cell MedX Corp
OTC:CMXC

Watchlist Manager

Cell MedX Corp

OTC:CMXC

Watchlist

Dividends

Discount Rate

Price: 134.435 USD -1.74%

Market Cap: 40B USD

Have any thoughts about
Cell MedX Corp?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 134.435 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

CMXC Alert

Cell MedX Corp

134.435

-1917.865 (-93.45%)

52 Week Range	134.435 2 752.575
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Cell MedX Corp

What unique competitive advantages
does Cell MedX Corp hold over its rivals?

What risks and challenges
does Cell MedX Corp face in the near future?

Provide an overview of the primary business activities
of Cell MedX Corp.

Show all valuation multiples
for Cell MedX Corp.

Provide an overview of the primary business activities
of Cell MedX Corp.

What unique competitive advantages
does Cell MedX Corp hold over its rivals?

What risks and challenges
does Cell MedX Corp face in the near future?

Has there been any significant insider trading activity
in Cell MedX Corp recently?

Show all valuation multiples
for Cell MedX Corp.

Provide P/S
for Cell MedX Corp.

Provide P/E
for Cell MedX Corp.

Provide P/OCF
for Cell MedX Corp.

Provide P/FCFE
for Cell MedX Corp.

Provide P/B
for Cell MedX Corp.

Provide EV/S
for Cell MedX Corp.

Provide EV/GP
for Cell MedX Corp.

Provide EV/EBITDA
for Cell MedX Corp.

Provide EV/EBIT
for Cell MedX Corp.

Provide EV/OCF
for Cell MedX Corp.

Provide EV/FCFF
for Cell MedX Corp.

Provide EV/IC
for Cell MedX Corp.

Compare the intrinsic valuations
of Cell MedX Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Cell MedX Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Cell MedX Corp compared to its peers.

Compare the P/E ratios
of Cell MedX Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Cell MedX Corp with its peers.

Analyze the financial leverage
of Cell MedX Corp compared to its main competitors.

Show all profitability ratios
for Cell MedX Corp.

Provide ROE
for Cell MedX Corp.

Provide ROA
for Cell MedX Corp.

Provide ROIC
for Cell MedX Corp.

Provide ROCE
for Cell MedX Corp.

Provide Gross Margin
for Cell MedX Corp.

Provide Operating Margin
for Cell MedX Corp.

Provide Net Margin
for Cell MedX Corp.

Provide FCF Margin
for Cell MedX Corp.

Show all solvency ratios
for Cell MedX Corp.

Provide D/E Ratio
for Cell MedX Corp.

Provide D/A Ratio
for Cell MedX Corp.

Provide Interest Coverage Ratio
for Cell MedX Corp.

Provide Altman Z-Score Ratio
for Cell MedX Corp.

Provide Quick Ratio
for Cell MedX Corp.

Provide Current Ratio
for Cell MedX Corp.

Provide Cash Ratio
for Cell MedX Corp.

What is the historical Revenue growth
over the last 5 years for Cell MedX Corp?

What is the historical Net Income growth
over the last 5 years for Cell MedX Corp?

What is the current Free Cash Flow
of Cell MedX Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Cell MedX Corp.

CMXC

Balance Sheet

Total Equity

Cell MedX Corp
Total Equity

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Cell MedX Corp
Total Equity Peer Comparison

Comparables:

BDX

BSX

SYK

ABT

ISRG

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

	Total Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
Cell MedX Corp OTC:CMXC	Total Equity -$826.5k	CAGR 3-Years 19%	CAGR 5-Years 14%	CAGR 10-Years N/A
Becton Dickinson and Co NYSE:BDX	Total Equity $25.9B	CAGR 3-Years 2%	CAGR 5-Years 4%	CAGR 10-Years 17%
Boston Scientific Corp NYSE:BSX	Total Equity $20.7B	CAGR 3-Years 8%	CAGR 5-Years 16%	CAGR 10-Years 12%
Stryker Corp NYSE:SYK	Total Equity $20.1B	CAGR 3-Years 12%	CAGR 5-Years 10%	CAGR 10-Years 9%
Abbott Laboratories NYSE:ABT	Total Equity $39.3B	CAGR 3-Years 5%	CAGR 5-Years 4%	CAGR 10-Years 6%
Intuitive Surgical Inc NASDAQ:ISRG	Total Equity $15.6B	CAGR 3-Years 11%	CAGR 5-Years 15%	CAGR 10-Years 18%

What is Cell MedX Corp's Total Equity?

Total Equity
-826.5k USD

Based on the financial report for May 31, 2024, Cell MedX Corp's Total Equity amounts to -826.5k USD.

What is Cell MedX Corp's Total Equity growth rate?

Total Equity CAGR 5Y
14%

Over the last year, the Total Equity growth was 65%. The average annual Total Equity growth rates for Cell MedX Corp have been 19% over the past three years , 14% over the past five years .

Cell MedX Corp
OTC:CMXC

Cell MedX Corp
Total Equity

Cell MedX Corp
Total Equity Peer Comparison

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

See Also

What is Cell MedX Corp's Total Equity?

Total Equity
-826.5k USD

What is Cell MedX Corp's Total Equity growth rate?

Total Equity CAGR 5Y
14%

Company

Help

Tools

Stocks

Cell MedX Corp OTC:CMXC

Cell MedX Corp Total Equity

Cell MedX Corp Total Equity Peer Comparison

Competitive Total Equity Analysis Latest Figures & CAGR of Competitors

See Also

What is Cell MedX Corp's Total Equity? Total Equity -826.5k USD

What is Cell MedX Corp's Total Equity growth rate? Total Equity CAGR 5Y 14%

Company

Help

Tools

Stocks

Cell MedX Corp
OTC:CMXC

Cell MedX Corp
Total Equity

Cell MedX Corp
Total Equity Peer Comparison

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

What is Cell MedX Corp's Total Equity?

Total Equity
-826.5k USD

What is Cell MedX Corp's Total Equity growth rate?

Total Equity CAGR 5Y
14%